ODYY (Odyssey Health) Cyclically Adjusted PB Ratio: (As of Jul. 14, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Odyssey Health Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Odyssey Health  (OTCPK:ODYY) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Odyssey Health Cyclically Adjusted PB Ratio Related Terms


Odyssey Health Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for Odyssey Health's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Odyssey Health Cyclically Adjusted PB Ratio Chart

Odyssey Health Annual Data
Trend Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23 Jul24 Jul25
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Odyssey Health Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 37.87 0.00 0.00 0.00 0.00

ODYY vs SSKN, NUMD, PFSA: Cyclically Adjusted PB Ratio Comparison

For the Medical Devices subindustry, Odyssey Health's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Odyssey Health Cyclically Adjusted PB Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Odyssey Health's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Odyssey Health's Cyclically Adjusted PB Ratio falls into.



Odyssey Health Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Odyssey Health's Cyclically Adjusted Book per Share for the quarter that ended in Apr. 2026 is calculated as:

For example, Odyssey Health's adjusted Book Value per Share data for the three months ended in Apr. 2026 was:

Adj_Book=Book Value per Share/CPI of Apr. 2026 (Change)*Current CPI (Apr. 2026)
=-0.097/333.0200*333.0200
=-0.097

Current CPI (Apr. 2026) = 333.0200.

Odyssey Health Quarterly Data

Book Value per Share CPI Adj_Book
201607 -0.002 240.628 -0.003
201610 -0.003 241.729 -0.004
201701 -0.003 242.839 -0.004
201704 -0.003 244.524 -0.004
201707 -0.004 244.786 -0.005
201710 -0.004 246.663 -0.005
201801 -0.006 247.867 -0.008
201804 -0.006 250.546 -0.008
201807 -0.013 252.006 -0.017
201810 -0.014 252.885 -0.018
201901 -0.013 251.712 -0.017
201904 -0.014 255.548 -0.018
201907 -0.007 256.571 -0.009
201910 0.248 257.346 0.321
202001 0.239 257.971 0.309
202004 0.231 256.389 0.300
202007 -0.007 259.101 -0.009
202010 -0.006 260.388 -0.008
202101 -0.011 261.582 -0.014
202104 -0.009 267.054 -0.011
202107 -0.032 273.003 -0.039
202110 -0.033 276.589 -0.040
202201 -0.051 281.148 -0.060
202204 -0.049 289.109 -0.056
202207 -0.060 296.276 -0.067
202210 -0.075 298.012 -0.084
202301 -0.071 299.170 -0.079
202304 -0.075 303.363 -0.082
202307 -0.078 305.691 -0.085
202310 -0.076 307.671 -0.082
202401 0.092 308.417 0.099
202404 0.082 313.548 0.087
202407 -0.055 314.540 -0.058
202410 -0.065 315.664 -0.069
202501 -0.067 317.671 -0.070
202504 -0.069 320.795 -0.072
202507 -0.072 323.048 -0.074
202510 -0.072 0.000
202601 -0.106 325.252 -0.109
202604 -0.097 333.020 -0.097

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Odyssey Health Business Description

Address 2300 West Sahara Avenue, Suite 800 - No. 4012, Las Vegas, NV, USA, 89102
Odyssey Health Inc is a developing medical and pharmaceutical technology that solves unmet clinical needs and has a substantial market opportunity. Its medical devices include CardioMap and Save-A-Life.